BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21697280)

  • 1. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.
    Labidi-Galy SI; Sisirak V; Meeus P; Gobert M; Treilleux I; Bajard A; Combes JD; Faget J; Mithieux F; Cassignol A; Tredan O; Durand I; Ménétrier-Caux C; Caux C; Blay JY; Ray-Coquard I; Bendriss-Vermare N
    Cancer Res; 2011 Aug; 71(16):5423-34. PubMed ID: 21697280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.
    Sisirak V; Faget J; Gobert M; Goutagny N; Vey N; Treilleux I; Renaudineau S; Poyet G; Labidi-Galy SI; Goddard-Leon S; Durand I; Le Mercier I; Bajard A; Bachelot T; Puisieux A; Puisieux I; Blay JY; Ménétrier-Caux C; Caux C; Bendriss-Vermare N
    Cancer Res; 2012 Oct; 72(20):5188-97. PubMed ID: 22836755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of conventional and plasmacytoid dendritic cells in swine secondary lymphoid organs and blood.
    Jamin A; Gorin S; Le Potier MF; Kuntz-Simon G
    Vet Immunol Immunopathol; 2006 Dec; 114(3-4):224-37. PubMed ID: 16978709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
    Lan CY; Liu JH; Xia JC; Zheng LM
    Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
    Wei S; Kryczek I; Zou L; Daniel B; Cheng P; Mottram P; Curiel T; Lange A; Zou W
    Cancer Res; 2005 Jun; 65(12):5020-6. PubMed ID: 15958543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.
    Le Mercier I; Poujol D; Sanlaville A; Sisirak V; Gobert M; Durand I; Dubois B; Treilleux I; Marvel J; Vlach J; Blay JY; Bendriss-Vermare N; Caux C; Puisieux I; Goutagny N
    Cancer Res; 2013 Aug; 73(15):4629-40. PubMed ID: 23722543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
    Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
    Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
    Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
    Lenz P; Lowy DR; Schiller JT
    Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
    Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
    Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine thymic plasmacytoid dendritic cells.
    Okada T; Lian ZX; Naiki M; Ansari AA; Ikehara S; Gershwin ME
    Eur J Immunol; 2003 Apr; 33(4):1012-9. PubMed ID: 12672067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical swine fever virus induces activation of plasmacytoid and conventional dendritic cells in tonsil, blood, and spleen of infected pigs.
    Jamin A; Gorin S; Cariolet R; Le Potier MF; Kuntz-Simon G
    Vet Res; 2008; 39(1):7. PubMed ID: 18073094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells.
    Megjugorac NJ; Young HA; Amrute SB; Olshalsky SL; Fitzgerald-Bocarsly P
    J Leukoc Biol; 2004 Mar; 75(3):504-14. PubMed ID: 14742635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.
    Arimoto-Miyamoto K; Kadowaki N; Kitawaki T; Iwata S; Morimoto C; Uchiyama T
    Immunology; 2010 May; 130(1):137-49. PubMed ID: 20201989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells.
    Naranjo-Gómez M; Oliva H; Climent N; Fernández MA; Ruiz-Riol M; Bofill M; Gatell JM; Gallart T; Pujol-Borrell R; Borràs FE
    Eur J Immunol; 2007 Jul; 37(7):1764-72. PubMed ID: 17523134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.
    Jaehn PS; Zaenker KS; Schmitz J; Dzionek A
    Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.